4/A//SEC Filing
Elrod James W 4/A
Accession 0001209191-11-004302
CIK 0001047699other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 6:05 PM ET
Size
5.5 KB
Accession
0001209191-11-004302
Insider Transaction Report
Form 4/AAmended
Elrod James W
Chief Legal Officer, Secretary
Transactions
- Award
Common Stock
2011-01-07+17,540→ 207,448 total
Footnotes (2)
- [F1]Reflects shares of common stock earned in connection with Long Term Performance Units (Three-Year Cycle) awarded under the King Pharmaceuticals, Inc. Incentive Plan on March 25, 2008.
- [F2]This amended Form 4 corrects the inadvertent omission from the original statement of certain shares and vested Long-Term Performance Units beneficially owned by the reporting person following this reported transaction.
Documents
Issuer
KING PHARMACEUTICALS INC
CIK 0001047699
Entity typeother
Related Parties
1- filerCIK 0001354792
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 6:05 PM ET
- Size
- 5.5 KB